Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Clinical trial NCT03026140 · RECRUITING
Trial details
- NCT number
- NCT03026140
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-29
- Primary completion
- 2032-03-01
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.